1）Hypothalamic orexin prevents hepatic insulin resistance via daily bidirectional regulation of autonomic nervous system in mice.
Tsuneki H, Tokai E, Nakamura Y, Takahashi K, Fujita M, Asaoka T, Kon K, Anzawa Y, Wada T, Takasaki I, Kimura K, Inoue H, Yanagisawa M, Sakurai T, Sasaoka T.
Diabetes. 2015; 64: 459-470.

2）Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes.
Kato H, Nagai Y, Ohta A, Tenjin A, Nakamura Y, Tsukiyama H, Sasaki Y, Fukuda H, Ohshige T, Terashima Y, Sada Y, Kondo A, Sasaoka T, Tanaka Y.
Diabetes Res Clin Pract. 2015; 109-205.

3）Teneligliptin improves metabolic abnormalities in a mouse model of postmenopausal obesity.
Sameshima A, Wada T, Ito T, Kashimura A, Sawakawa K, Yonezawa R, Tsuneki H, Ishii Y, Sasahara M, Saito S, Sasaoka T.
J Endocrinol. 2015; 227: 25-36.

5）Orexin regulates glucose homeodynamics with daily rhythm.
Tsuneki H, Wada T, Sasaoka T.
Orexin and Sleep. 2015; 381-394.